Chloroquine as an Autophagy Inhibitor for Research Excell...
2025-10-21
Chloroquine stands out as a dual autophagy and Toll-like receptor inhibitor, empowering researchers to dissect complex immune and degradation pathways in malaria and rheumatoid arthritis models. Its robust solubility and reproducible activity make it indispensable for high-impact, mechanistically driven workflows. Discover how to harness Chloroquine’s full research potential with protocol optimizations, troubleshooting guidance, and forward-looking strategies.